If you want to find something quickly, knowing what not to look for can help speed up the process, researchers say.
New research from Johns Hopkins University has found that the art of ignoring can be used to improve search performance, but only after people have been given time to practice.
Tech 2000, Inc. (Tech 2000), a leading education technology and solutions company, has added two new directors to its board of directors, Bruce Klein and Paul Opalack.
“Adding these two technology rockstars to our board will help us aggressively expand Tech 2000, as well as our appnetic and Lumious enterprise software businesses,” said Tien Wong, CEO of Tech 2000. Klein and Opalack will help shape future strategy for not only Tech 2000’s core business of corporate learning and development, software development, and learning tools and analytics, but also the company’s two software as a service (SaaS) businesses: sales acceleration platform appnetic, and learning analytics platform Lumious.
The health foundation of Microsoft billionaire Bill Gates is in talks with Latin American governments and scientists over plans to spread hundreds of millions of mosquitoes that are unable to transmit dengue fever and Zika virus.
The discussions include a proposal by scientists in Medellín, Colombia, to spend $16 million to try to protect the city’s three million people with the new breed of mosquitoes.
Funding and Research Opportunities The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
Notices:
Wednesday, March 9, 2016 from 3:30 PM to 5:00 PM (EST)
Montgomery County Department of Economic Development – 111 Rockville Pike Suite 800 Rockville, MD 20850
The National Oceanic and Atmospheric Administration (NOAA) is based on Silver Spring, MD, but is served by laboratories and science centers across the country. From severe weather and climate to ocean and coastal sciences, NOAA’s work is extremely varied and offers a number of opportunities for MD companies. This presentation from NOAA’s Technology Partnerships Office will provide an overview of NOAA’s science activities, as well as ways private sector companies can work with NOAA.
Biohealth is all over the map in Maryland. There’s the biotech corridor in Montgomery County, where companies like MedImmune LLC and Emergent BioSolutions Inc. call home. The students and academic researchers at Johns Hopkins and University of Maryland are up in Baltimore. Then there are the government agencies and their many, many contractors spread throughout the Baltimore-Washington region.
Chris Frew wanted to find a way to connect all the dots.
Enter BioHive, an online community engagement website for the movers and shakers of biohealth.
The week of April 3-9 Paul Singh, a successful entrepreneur and seed-stage investor, will visit Los Alamos, Taos, Santa Fe and Albuquerque to deliver a week-long series of events for aspiring entrepreneurs and community members.
China will develop traditional Chinese medicine (TCM) into a pillar industry, according to a blueprint released by the State Council, China’s Cabinet, on Friday.
The plan proposes universal access to TCM care by 2020. By 2030, TCM should make a notably greater contribution to social and economic development.
In 2011, when the University System of Maryland Board of Regents was considering a merger of the College Park and Baltimore campuses of the University of Maryland, we supported the idea. The pure-research-focused flagship in College Park and the professional school campus in Baltimore had little combined activity and were missing key potential opportunities for cross-disciplinary scholarship and teaching and for economic development. Given how crucial the knowledge economy is to Maryland’s future, we urged leaders to look past parochial concerns and take advantage of the opportunities a combined university could provide.
Opdivo from Bristol-Myers Squibb ($BMY) followed Merck’s ($MRK) Keytruda onto the market, but the immuno-oncology drug quickly overtook its rival and has never looked back. It just today won recommendations in Europe for two more indications. But while it leads the race, analysts say there are still opportunities for Keytruda and drug candidates from others to close the gap in a market that is projected to reach $40 billion in annual sales.
